Insiders who reported open-market trades in the last 12 months at the companies John Paulson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
PAULSON CO. INC. - $15.63M in BHC purchases and sales in the last 12 months
Aimee J. Lenar - $259K in BHC purchases and sales in the last 12 months
Frank D. Lee - $133K in BHC purchases and sales in the last 12 months
Seana Carson - $115K in BHC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
John Paulson is a corporate insider, tracked as Director of Bausch Health Companies Inc. (BHC). InsiderAlpha holds 17 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John Paulson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has John Paulson been buying or selling stock?
Recorded transactions: 4 open-market purchases ($333.76M) and 0 open-market sales across all tracked filings.
John Paulson is Director of Bausch Health Companies Inc. (BHC). 17 SEC Form 4 filings on record going back to 2024, most recently on 2 October 2026. Most recent open-market trade: bought $312.49M of BHC on 15 August 2025. Lifetime open-market purchases: $333.76M.
Recent transactions
17
The latest 17 SEC Form 4 transactions reported by John Paulson.
InsiderAlpha's records for John Paulson go back to 2024: 17 primary Form 4 filings, an average of 5.7 per year. The typical open-market purchase is $83.44M (4 buys totaling $333.76M). The largest single buy on record is $312.49M of BHC in 2025. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
